ClinicalTrials.Veeva

Menu

Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus (SLE-ARTEMIS)

AstraZeneca logo

AstraZeneca

Status

Enrolling

Conditions

Lupus Erythematosus, Systemic

Treatments

Drug: Anifrolumab

Study type

Observational

Funder types

Industry

Identifiers

NCT06673043
D3461R00082

Details and patient eligibility

About

The Polish multicentre observational (non-interventional) study aiming to collect data on the characteristic of patients with systemic lupus erythematosus and clinical outcomes of anifrolumab administered in the scope of routine clinical practice.

Full description

This is multicenter, observational, cohort study designed to collect longitudinal data on the management and clinical outcomes of patients with SLE that received anifrolumab in the scope of routine clinical practice within the frames of National Drug Program (NDP) for up to 30 months (~ 6 months baseline and ~24 months follow-up date).

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adult (aged ≥18 years old) patients with SLE who received anifrolumab treatment in the frames of NDP in Poland.
  2. Patients willing to participate in the study and signed Informed Consent Form (ICF).

Exclusion criteria

  1. Those who participated in anifrolumab clinical trial in the past, and/or those who participated/plans to participate in clinical trial on/after the date of first anifrolumab infusion through NDP.
  2. Cognitive incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.

Trial design

100 participants in 1 patient group

SLE Patients
Description:
Open-lable arm with SLE patients who received anifrolumab treatment in the frames of NDP in Poland.
Treatment:
Drug: Anifrolumab

Trial contacts and locations

12

Loading...

Central trial contact

AstraZeneca Clinical Study Information Center

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems